-
AI needs safety layers like nuclear plants: ex-OpenAI engineer
-
Fury to invite Trump to lead ring walk before Joshua showdown
-
MVP Judge will miss Yankees' MLB playoff series against Rays
-
Fashion industry in 'precarious moment', says Vivienne Westwood supremo
-
New lizard species discovered in Peru
-
Seventh heaven for England in Nations League rout of Croatia
-
Fernandes hails Portugal's 'greatest symbol' Ronaldo, calls for unity
-
Storms, flooding cause chaos on Greek holiday island of Crete
-
Grandidier-Nkanang double takes Pau to Top 14 summit despite Vannes fightback
-
#IAmJaneDoe: online support campaign in US university rape case
-
Trainer Scott gets perfect Arc boost with top notch double
-
Brazil shine on Selecao's first visit to India
-
Ex-PM says Putin cannot admit 'mistake' over Ukraine
-
Zverev sets up Djokovic quarter-final at China Open, Rybakina out
-
Houthis say Saudi Arabia launches dozens of strikes on Yemen capital
-
Happier at home, Bordeaux hammer Lyon in Top 14
-
Qatar and Abu Dhabi F1 Grand Prix to go ahead - F1 boss
-
Lula, Bolsonaro in final push for votes ahead of knife-edge election
-
South Korea lift gloom with smash-and-grab Games football gold
-
Boisterous fashion week barnstorms 'sleepy' Nigerian capital
-
Ireland news conference before Israel game cut short amid tensions
-
UAE investigators say flydubai co-pilot was planning 'terrorist act'
-
Protests over housing flare in Spain after relief measures rejected
-
Rahul smacks century in India v Windies ODI
-
Zverev thrashes Shang to set up Djokovic quarter-final at China Open
-
Daryz seeks to join exclusive club of dual Arc winners
-
Turkey football ref chief jailed pending trial for graft
-
Russia warns diplomats to leave Kyiv over new strikes threat
-
North Korea says test of intermediate-range strategic missile included use of AI
-
Olympic champ Zheng rebukes rowdy home crowd at China Open
-
Rampant Sayers leads Hong Kong to third men's rugby gold in a row
-
World No.1 Sinner pulls out of Shanghai Masters to delay return
-
Ethiopia's Tigray rebels abandon regional capital as govt advances
-
Red Bull's Verstappen grabs pole position for Bahrain GP
-
Bulgaria's Tsar Samuel returns 'home' after 1,000 years
-
India beat Pakistan in blockbuster as golfer Kim wins 'crazy' gold
-
'Glad it's over': Kim powers to Games gold and military exemption
-
India beat arch-rivals Pakistan to win Asian Games cricket gold
-
After 11 World Cups, football finally comes home for one Indian fan
-
Ethiopia's Tigray rebels abandon regional capital as govt advances: journalist
-
Marc Marquez wins sprint at Japan MotoGP, Martin grabs pole
-
Tom Kim powers to Games gold and exemption from military service
-
Alcaraz fends off Arnaldi to reach Japan Open quarters
-
Split loyalties for Indian football fans at Brazil friendly
-
Antonelli tops times in final practice at Bahrain GP
-
India-Pakistan blockbuster brings cricket fever to Japan baseball field
-
Gauff digs deep to beat Osorio in China Open second round
-
Wong waiting on Rafa after winning Asian Games tennis gold
-
Fresh protests to hit Spain after housing measures defeated
-
With Russia next door and rising costs, Latvia goes to the polls
New US strategy to make monkeypox vaccine go further
US health authorities on Tuesday authorized a new procedure for injecting the monkeypox vaccine that should make it possible to inoculate more people with the same amount of the drug, at a time when doses are running short in the country.
The Food and Drug Administration also authorized giving the vaccine to people under the age of 18 who are considered to be at high risk of infection.
For those over 18, health workers will now be able to administer the vaccine differently, via an intradermal injection -- that is, between the upper layers of the skin -- and not with a deeper, subcutaneous injection.
The new method will "increase the total number of doses available for use by up to five-fold," the FDA said in a statement.
Two injections, four weeks apart, will still be necessary.
The FDA said it was drawing on data from a 2015 clinical trial that showed a similar immune response in people given a subcutaneous injection compared to those given a fifth of the dose via an intradermal shot.
At present, some 620,000 doses of the vaccine -- manufactured by Bavarian Nordic, and marketed under the name Jynneos in the United States -- have been distributed across the country.
Another 440,000 additional doses are still to be distributed, which could allow up to 2.2 million injections under the new strategy.
The government has also ordered an additional five million doses, which will start arriving from September and run through 2023, affording the potential to administer 25 million doses.
The decisions came after the FDA issued an emergency use authorization for the vaccine, a move that itself followed the declaration of a public health emergency last week.
For the authorization in minors, the FDA said it had reviewed safety data for the vaccine, as well as data for another vaccine given in children against smallpox.
"We feel very comfortable with the safety of the approach," said Peter Marks of the FDA at a press conference, noting a recent increase in the number of children who have potentially been exposed to infected people.
The United States has registered nearly 9,000 cases of monkeypox, a fifth of them in New York state. The vast majority of cases involve men who have had sex with men.
F.Pavlenko--BTB